IWMF Pilot Clinical Trial Grants
The International Waldenstrom's Macroglobulinemia Foundation Inc
Funding Amount
Up to US $1,000,000
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Other requirements
- Applicants must hold an MD, PhD, or equivalent degree and work in domestic or foreign non-profit organizations, such as universities, colleges, hospitals, or laboratories.
- Applicants should have an independent research or academic position.
- Applicants need not be US citizens, and there are no restrictions on applicant age, race, gender, or creed.
- Applicants can apply for more than one Grant.
Not eligible / not funded
- Not eligible: Applicants from non-academic facilities and postdoctoral positions are not eligible.
Overview
Applying for a Research Grant
IWMF seeks applications for research and clinical studies that will deliver meaningful therapeutic benefits for Waldenstrom macroglobulinemia (WM) patients within the next 3–5 years. Grant amounts range from $250K–$1M over 2–4 years, with a separate award to support young investigators.
Working in partnership with our world-class Scientific Advisory Committee, IWMF has developed an updated 2026 Strategic Research Agenda to advance innovative discoveries, support novel clinical trials, and foster collaborations that will continue to revolutionize treatments for WM.
IWMF seeks to support independent investigators affiliated with academic institutions using investigator-initiated trials (IITs) to undertake clinical studies of novel agents, novel combinations, or new immunotherapies with potential for clinical breakthroughs in Waldenstrom macroglobulinemia (WM) patients. These clinical studies are designed to demonstrate proof-of-concept and produce compelling results in a limited number of patients. Successful study results will provide validation to initiate larger clinical studies to achieve new therapy inclusion in NCCN Guidelines, FDA approval, or other comparable regulatory approvals in the future.
Importantly, studies should be designed to achieve complete responses and MRD-negativity, leading to the IWMF’s goal of enhancing long-term disease control (a functional cure) and ultimately, complete cures (discontinuation of any therapy). Applicants should provide a detailed explanation of the proposed rationale, prior clinical data to support the thesis, and a clear rationale for the overall duration and projected schedule for milestone-based payments throughout the Grant period.
Eligibility
Applicants must hold an MD, PhD, or equivalent degree and work in domestic or foreign non-profit organizations, such as universities, colleges, hospitals, or laboratories. Applicants should have an independent research or academic position. Applicants need not be US citizens, and there are no restrictions on applicant age, race, gender, or creed. Applicants can apply for more than one Grant.
Ineligibility
Applicants from non-academic facilities and postdoctoral positions are not eligible.
What The International Waldenstrom's Macroglobulinemia Foundation Inc actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 6
- Total given
- $2.14M
- Median grant
- $200K
- Range
- $30K–$1.26M
- By dollars: Massachusetts 74%, Minnesota 20%, Ohio 4%. Top recipient cities: Boston, MA; Mineapolis, MN; Columbus, OH.
- 0% of grants with a stated purpose were for general or operating support.
Example grants
Dana Farber Cancer Institute · Boston, MA
Research
$1.26M
Mayo Clinic · Mineapolis, MN
Research
$421K
NYU School of Medicine · Boston, MA
Research
$320K
The Ohio State University · Columbus, OH
Research
$80K
University of CA San Diego · La Jolla, CA
Research
$30K
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
2026 Research Request for Proposals (RFP)
The International Waldenstrom's Macroglobulinemia Foundation Inc
Amount
$250,000 - $1,000,000 over 2-4 years
Deadline
Deadline not published
Companion Grant
The International Waldenstrom's Macroglobulinemia Foundation Inc
Amount
$120,000 total
Deadline
Deadline not published
Seed Money Initiative
The International Waldenstrom's Macroglobulinemia Foundation Inc
Amount
$90,000 each (one-year awards)
Deadline
Deadline not published
Enhanced Roadmap Grant
The International Waldenstrom's Macroglobulinemia Foundation Inc
Amount
$1,500,000 total
Deadline
Deadline not published
Robert A. Kyle Career Development Awards
The International Waldenstrom's Macroglobulinemia Foundation Inc
Amount
$157,500 each (two-year awards)
Deadline
Deadline not published
Strategic Research Roadmap Grants
The International Waldenstrom's Macroglobulinemia Foundation Inc
Amount
$480,000 total
Deadline
Deadline not published
Ready to apply for IWMF Pilot Clinical Trial Grants?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found IWMF Pilot Clinical Trial Grants. Now let's win it.